Cortina Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Cortina Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$5.01M	Sell	70,402 -593	-0.8%	-$43.7K	0.31%	137
2019 Q1	$5.57M	Buy	70,995 +5,929	+9%	+$449K	0.35%	119
2018 Q4	$5.51M	Buy	65,066 +32,370	+99%	+$3.45M	0.34%	112
2018 Q3	$5.6M	Sell	32,696 -23,710	-42%	-$3.57M	0.26%	144
2018 Q2	$7.29M	Buy	56,406 +5,671	+11%	+$633K	0.34%	100
2018 Q1	$5.23M	Sell	50,735 -6,838	-12%	-$676K	0.26%	149
2017 Q4	$4.92M	Sell	57,573 -14,777	-20%	-$1.28M	0.22%	179
2017 Q3	$6.14M	Sell	72,350 -35,093	-33%	-$2.78M	0.25%	143
2017 Q2	$8.14M	Buy	107,443 +25,595	+31%	+$1.79M	0.34%	88
2017 Q1	$5.4M	Buy	+81,848	New	+$5.38M	0.22%	162
2015 Q3	–	Sell	-130,720	Closed	-$8.23M	–	242
2015 Q2	$8.23M	Sell	130,720 -31,481	-19%	-$1.72M	0.36%	123
2015 Q1	$7.8M	Buy	+162,201	New	+$6.21M	0.34%	121

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Cortina Asset Management's LGND Position: Q2 2019 in Review

Cortina Asset Management reduced its Ligand Pharmaceuticals (LGND) stake by 0.84% in Q2 2019, selling an estimated $43.7K and leaving 70,402 shares worth $5.01M. The position accounts for 0.31% of the portfolio, ranked #137.

Cortina Asset Management first reported a position in LGND in Q1 2015 and has held it in 12 quarters since. The position peaked at $8.23M in Q2 2015. 305 funds tracked by Wall St. Rank hold LGND as of Q2 2019.

Cortina Asset Management held 70,402 shares of Ligand Pharmaceuticals worth $5.01M as of Q2 2019.
Cortina Asset Management sold 593 Ligand Pharmaceuticals shares in Q2 2019, an estimated $43.7K.
Ligand Pharmaceuticals made up 0.31% of Cortina Asset Management's portfolio in Q2 2019, its #137 holding.
Cortina Asset Management first reported a position in Ligand Pharmaceuticals in Q1 2015 and has held it in 12 quarters since.
Cortina Asset Management's Ligand Pharmaceuticals position peaked at $8.23M in Q2 2015.
305 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2019.

Based on Cortina Asset Management's 13F filing for Q2 2019, filed 2 Jul 2019.